Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

GenomSys said Wednesday that it has received CE marking for the GenomSys Variant Analyzer. The genomic analysis software adheres to the MPEG-G genomic data representation and compression standard, which GenomSys has championed.

The GenomSys Variant Analyzer integrates curated variant databases from Varsome to automate genome annotation. According to GenomSys, a startup specializing in DNA data processing software, the use of MPEG-G helps the new product deliver faster data access time and smaller storage requirements.

“We designed GenomSys Variant Analyzer for the analysis of the vast amount of data generated by whole-exome sequencing to support geneticists in deciphering the causes of rare disorders,” CSO Luca Trotta said in a statement.

More information on the news you will find here.

Schedule a call

[contact-form-7 id="224" title="contact call"]